FDA Inspection 1085327 — Samsung Bioepis Co., Ltd.
The FDA completed an inspection of Samsung Bioepis Co., Ltd. on February 15, 2019 in Yeonsu. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- February 15, 2019
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Yeonsu (Korea (the Republic of))